Pharmacological inhibition of HPK1 synergizes with PD-L1 blockade to provoke antitumor immunity against tumors with low antigenicity is a research paper published in Biochemical and Biophysical Research Communications (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Daiichi Sankyo Co Ltd
National Cancer Institute
Daiichi-Sankyo
National Institutes of Health
Daiichi Sankyo Europe
U.S. Department of Health and Human Services
FWCI
1.60
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals